Raising the Alarmone: Within-Host Evolution of Antibiotic-Tolerant Enterococcus faecium

• Published in: mBio Vol. 8; no. 1
• Main Authors: Van Tyne, Daria, Gilmore, Michael S.
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 21.02.2017
• Subjects: Anti-Bacterial Agents; Enterococcus - drug effects; Enterococcus faecium - drug effects; Gastrointestinal Tract - drug effects; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance - drug effects
• ISSN: 2161-2129; 2150-7511; 2150-7511
• DOI: 10.1128/mBio.00066-17

Enterococci are ancient commensal bacteria that recently emerged as leading causes of antibiotic-resistant, hospital-acquired infection. Vancomycin-resistant enterococci (VRE) epitomize why drug-resistant enterococcal infections are a problem: VRE readily colonize the antibiotic-perturbed gastrointestinal (GI) tract where they amplify to large numbers, and from there, they infect other body sites, including the bloodstream, urinary tract, and surgical wounds. VRE are resistant to many antimicrobials and host defenses, which facilitates establishment at the site of infection and confounds therapeutic clearance. Having evolved to colonize the GI tract, VRE are comparatively ill adapted to the human bloodstream. A recent study by Honsa and colleagues (E. S. Honsa et al., mBio 8:e02124-16, 2017, https://doi.org/10.1128/mBio.02124-16 ) found that a strain of vancomycin-resistant Enterococcus faecium evolved antibiotic tolerance within the bloodstream of an immunocompromised host by activating the stringent response through mutation of relA . Precisely how VRE colonize and infect and the selective pressures that led to the outgrowth of relA mutants are the subjects of ongoing research.